Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

OBJECTIVE: Thiazolidinediones reduce hepatic steatosis and increase HDL cholesterol levels. In mice with human-like lipoprotein metabolism (APOE*3-Leiden.CETP transgenic mice), a decrease in hepatic triglyceride content is associated with a decrease in plasma cholesteryl ester transfer protein (CETP...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonker, Jacqueline T., Wang, Yanan, de Haan, Willeke, Diamant, Michaela, Rijzewijk, Luuk J., van der Meer, Rutger W., Lamb, Hildo J., Tamsma, Jouke T., de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Smit, Johannes W.A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890371/
https://www.ncbi.nlm.nih.gov/pubmed/20150294
http://dx.doi.org/10.2337/dc09-1935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890371/
https://www.ncbi.nlm.nih.gov/pubmed/20150294
http://dx.doi.org/10.2337/dc09-1935

Ejemplares similares